IPU RX-2— 510(k) K964327

Substantially Equivalent

Medirex, Inc.

FDA 510(k) clearance K964327 for IPU RX-2, Substantially Equivalent on 1997-01-17. Applicant: Medirex, Inc..

Clearance details

Applicant: Medirex, Inc.
Product code: Code LLZ
Advisory panel: Radiology
Date received: 1996-10-30
Decision date: 1997-01-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Wellesley Hills, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.